Outcome of three-fraction gamma knife radiosurgery for brain metastases according to fractionation scheme: preliminary results.
Brain metastases
Fractionation schedule
Interfraction interval
Three-fraction gamma knife radiosurgery
Journal
Journal of neuro-oncology
ISSN: 1573-7373
Titre abrégé: J Neurooncol
Pays: United States
ID NLM: 8309335
Informations de publication
Date de publication:
Oct 2019
Oct 2019
Historique:
received:
19
06
2019
accepted:
17
08
2019
pubmed:
26
8
2019
medline:
15
2
2020
entrez:
26
8
2019
Statut:
ppublish
Résumé
The optimal interfraction intervals for fractionated radiosurgery has yet to be established. We investigated the outcome of fractionated gamma knife radiosurgery (FGKRS) for large brain metastases (BMs) according to different interfraction intervals. Between September 2016 and May 2018, a total of 45 patients who underwent FGKRS for BMs were enrolled in this study. They were divided into two groups (standard fractionation over 3 consecutive days with a 24-h interfraction interval versus prolonged fractionation over 4 or 5 days with an interfraction interval of at least 48-h). BMs with ≥ 2 cm in maximum diameter or ≥ 5 cm Among 52 BMs treated with 3-fraction GKRS, 25 (48.1%) were treated with standard fractionation scheme, and 27 (51.9%) with prolonged fractionation scheme. The median follow-up period was 10.5 months (range 5-25). Local tumor control rates of the standard group were 88.9% at 6 months and 77.8% at 12 months, whereas those of the prolonged group were 100% at 6 and 12 months (p = 0.023, log-rank test). In multivariate analysis, fractionation scheme (hazard ratio [HR] 0.294, 95% CI 0.099-0.873; p = 0.027) and tumor volume (HR 0.200, 95% CI 0.051-0.781; p = 0.021) were revealed as the only significant factors affecting the local tumor control after 3-fraction GKRS. Our preliminary tumor control results suggest a promising role of 3-fraction GKRS with an interfraction interval of at least 48-h. This fractionation regimen could be an effective and safe treatment option in the management of large BMs.
Identifiants
pubmed: 31446529
doi: 10.1007/s11060-019-03267-z
pii: 10.1007/s11060-019-03267-z
doi:
Types de publication
Clinical Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
65-74Références
J Neurooncol. 2009 Jan;91(2):207-12
pubmed: 18807149
AJNR Am J Neuroradiol. 2014 Jul;35(7):1309-17
pubmed: 24676005
J Neurooncol. 2012 Aug;109(1):159-65
pubmed: 22544651
Int J Radiat Oncol Biol Phys. 2014 Feb 1;88(2):254-62
pubmed: 24411596
Int J Radiat Oncol Biol Phys. 1991 Aug;21(3):819-24
pubmed: 1869472
J Radiat Res. 2012;53(1):1-9
pubmed: 21997195
Int J Radiat Oncol Biol Phys. 2019 Mar 2;:null
pubmed: 30836165
PLoS One. 2016 Sep 23;11(9):e0163304
pubmed: 27661613
Radiat Oncol. 2011 May 15;6:48
pubmed: 21575163
J Neurosurg. 2018 Sep 7;:1-11
pubmed: 30192195
Int J Radiat Oncol Biol Phys. 2000 May 1;47(2):291-8
pubmed: 10802351
JAMA. 2016 Jul 26;316(4):401-409
pubmed: 27458945
Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):483-9
pubmed: 20800386
J Radiosurg SBRT. 2012;2(1):19-27
pubmed: 29296339
Med Phys. 2005 Dec;32(12):3666-77
pubmed: 16475766
J Korean Med Sci. 2019 Feb 12;34(8):e57
pubmed: 30833881
J Neurosurg. 2006 Jan;104(1):157-62
pubmed: 16509161
J Neurosurg. 2013 Jun;118(6):1258-68
pubmed: 23600938
Cancer Manag Res. 2018 Jul 05;10:1889-1899
pubmed: 30013395
J Neurosurg. 2009 Mar;110(3):547-52
pubmed: 18821832
Neurosurgery. 2018 Jul 1;83(1):114-121
pubmed: 28973432
J Radiat Res. 2013 Mar 1;54(2):367-73
pubmed: 23077237
Int J Radiat Oncol Biol Phys. 2016 Jul 15;95(4):1142-8
pubmed: 27209508
Cancer. 2012 Apr 15;118(8):2078-84
pubmed: 22009495
J Korean Neurosurg Soc. 2015 Sep;58(3):217-24
pubmed: 26539264
J Neurosurg. 2016 Jan;124(1):146-54
pubmed: 26162039
J Radiat Res. 2016 Aug;57 Suppl 1:i76-i82
pubmed: 27006380
Int J Radiat Oncol Biol Phys. 2017 Sep 1;99(1):31-40
pubmed: 28816158
J Neurosurg. 2014 Dec;121 Suppl:16-25
pubmed: 25434933
Stereotact Funct Neurosurg. 1993;61 Suppl 1:59-64
pubmed: 8115757
Strahlenther Onkol. 2007 Nov;183(11):625-30
pubmed: 17960338
J Neurooncol. 2014 Apr;117(2):295-301
pubmed: 24488446
J Clin Oncol. 2015 Oct 20;33(30):3475-84
pubmed: 26282648
J Neurosurg. 2018 Dec 1;129(Suppl1):77-85
pubmed: 30544297
J Neurosurg. 2018 May;128(5):1380-1387
pubmed: 28707997
J Neurooncol. 2017 Feb;131(3):517-524
pubmed: 27832430
Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):623-9
pubmed: 23683828
Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1543-8
pubmed: 19135317
Radiat Oncol. 2014 Jun 10;9:132
pubmed: 24917309
Int J Radiat Oncol Biol Phys. 2003 Jul 1;56(3):793-800
pubmed: 12788187
J Neurosurg. 2018 Aug;129(2):366-382
pubmed: 28937324
Neurosurgery. 2017 Feb 1;80(2):210-216
pubmed: 28536486